Journal
/
Cancer Research
/
Modelado de los efectos del estrés hemodinámicon las células tumorales circulantes utilizando una jeringa y una aguja…
JoVE Journal
Cancer Research
Cancer Research
A subscription to JoVE is required to view this content.
Modelado de los efectos del estrés hemodinámico en las células tumorales circulantes utilizando una jeringa y una aguja
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/62478-v
•
05:49 min
•
April 27th, 2021
Modelado de los efectos del estrés hemodinámico en las células tumorales circulantes utilizando una jeringa y una aguja
April 27th, 2021
•
Devon L. Moose1,2, Sophia Williams-Perez3, Renee Cafun1, Benjamin L. Krog1, Michael D. Henry1,2,4,5,6
1Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, 2Holden Comprehensive Cancer Center, University of Iowa, 3MD program, Carver College of Medicine, University of Iowa, 4Department of Pathology, Carver College of Medicine, University of Iowa, 5Department of Urology, Carver College of Medicine, University of Iowa, 6Department of Radiation Oncology, Carver College of Medicine, University of Iowa
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Aquí demostramos un método para aplicar estrés por cizallamiento de fluidos a las células cancerosas en suspensión para modelar los efectos del estrés hemodinámico en las células tumorales circulantes.